VOYA Investment Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-11,737
Closed -$1.15M 2710
2015
Q1
$1.15M Hold
11,737
﹤0.01% 1369
2014
Q4
$1.09M Hold
11,737
﹤0.01% 1388
2014
Q3
$807K Hold
11,737
﹤0.01% 1569
2014
Q2
$1.23M Buy
11,737
+1,174
+11% +$99.9K ﹤0.01% 1365
2014
Q1
$876K Hold
10,563
﹤0.01% 1546
2013
Q4
$684K Hold
10,563
﹤0.01% 1721
2013
Q3
$669K Hold
10,563
﹤0.01% 1684
2013
Q2
$444K Buy
+10,563
New +$481K ﹤0.01% 1927

VOYA Investment Management's GEVA Position: Q2 2015 in Review

VOYA Investment Management sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 11,737 shares — an estimated $1.15M sold.

VOYA Investment Management first reported a position in GEVA in Q2 2013 and held it in 8 quarters. The position peaked at $1.23M in Q2 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • VOYA Investment Management reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • VOYA Investment Management sold 11,737 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $1.15M.
  • VOYA Investment Management first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • VOYA Investment Management's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $1.23M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on VOYA Investment Management's 13F filing for Q2 2015, filed 14 Aug 2015.